Delivery Order SPE2DB22D2211-SPE2DB24FMMW4
Award Date 1/4/24
Potential Completion Date 1/26/24
Potential Value $23K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OCREVUS 300 mg/10 ml vials. The total potential value of the award is $128,918.52, with a completion date of October 15, 2021. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to provide pharmaceuticals, medical supplies, and...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OCREVUS 300 mg/10 mL vials. The order has a potential value of $218,619.00 and a completion date of September 28, 2022. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense. This delivery order is...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OCREVUS 300 MG/10 ML VIAL 10ML. The delivery order has a potential value of $109,309.50 and a completion date of March 3, 2022. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA Troop Support Medical to provide pharmaceutical products...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The delivery order, with a potential value of $131,171.40, is for 300 mg/10 ml vials of the drug OCREVUS. The order was placed against an existing contract held by Amerisourcebergen Drug Corp to supply pharmaceuticals and medical supplies to DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of pharmaceutical products. Specifically, the order is for OCREVUS 300 MG/10 ML VIAL 10ML, a specialty medication. The firm fixed price delivery order has a potential value of $196,757.10 and a completion date of August 12, 2022. No set-aside designation was used. AmerisourceBergen Drug Corp, operating out of its corporate office...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The order is for the supply of OCREVUS 300 MG/10 ML VIAL 10ML, a pharmaceutical product, with a potential value of $135,712.32 and a completion date of June 30, 2023. This delivery order is part of Amerisourcebergen's existing indefinite delivery contract with...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the delivery of OCREVUS 300 MG/10 ML VIAL 10ML, a pharmaceutical product, with a potential value of $109,309.50 and a completion date of March 3, 2022. Amerisourcebergen Drug Corp, as a prime contractor, has received numerous federal contract awards from DLA to supply pharmaceuticals,...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $23,118.08 contract is for the delivery of OCREVUS 300 MG/10 ML VIAL 10ML, a pharmaceutical product, to support DLA Troop Support Medical programs and facilities. The order has a completion date of February 8, 2024. No set-aside designation was used for this contract....
- The Defense Logistics Agency awarded a $51,275.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Ocrevus 300 mg/10 mL vials. This competitive award with no set-aside designation is scheduled for completion by February 19, 2026, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $196,757.10 firm fixed price delivery order is for the supply of OCREVUS 300 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has a completion date of June 7, 2022 and was awarded on May 16, 2022. Amerisourcebergen Drug Corp, through its...